Nisa Investment Advisors
ATOS icon

Nisa Investment Advisors’s Atossa Therapeutics ATOS Stock Holding History

Nisa Investment Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$207 – 3044
2025
Q4 		$207 Hold
23
– – ﹤0.01% 2917
2025
Q3 		$303 Sell
23
-39
-63% -$482 ﹤0.01% 2915
2025
Q2 		$770 Sell
62
-8
-11% -$96 ﹤0.01% 2790
2025
Q1 		$707 Buy
70
+63
+900% +$765 ﹤0.01% 2724
2024
Q4 		$106 Sell
7
-18
-72% -$351 ﹤0.01% 2979
2024
Q3 		$578 Buy
+25
New +$505 ﹤0.01% 2697
2022
Q2 		– Sell
-553
Closed -$10K – 2375
2022
Q1 		$10K Buy
+553
New +$11.2K ﹤0.01% 2193

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nisa Investment Advisors's ATOS Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 23 shares — an estimated $207 sold.

Nisa Investment Advisors first reported a position in ATOS in Q1 2022 and held it in 7 quarters. The position peaked at $10K in Q1 2022. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • Nisa Investment Advisors reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 23 Atossa Therapeutics shares in Q1 2026, an estimated $207.
  • Nisa Investment Advisors first reported a position in Atossa Therapeutics in Q1 2022 and held it in 7 quarters.
  • Nisa Investment Advisors's Atossa Therapeutics position peaked at $10K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.